A 10-Day Winning Streak Has Clorox Stock Up 24%

• CLX stock rose 24.4% over 10 straight trading days, adding $2.6B in market value • Streak is company-specific: S&P 500 fell 0.2% over the same period • Fundamentals are mixed: above-median revenue growth, below-median margins, lower P/E than peers Clorox (CLX) has climbed for 10 consecutive sessions, gaining 24.4% and adding about $2.6 billion in market value to reach roughly $13.3 billion. Shares closed Friday at $109.46, 10.5% below their 52-week high and 38.1% above their low. The move looks idiosyncratic rather than market-driven: the S&P 500 fell 0.2% over the same 10 days, and no other S&P 500 stock is on a streak this long. Over the past three months CLX is up just 4.8% overall, meaning it fell 15.7% across the 53 sessions outside the streak. Fundamentally, the picture is mixed. Trailing twelve-month revenue growth of 6.3% beats the Consumer Staples median of 5.4%, and its 19.7x trailing P/E is below the 22.9x median. But its 14.1% operating margin trails the 14.9% median, so the rally isn't fully backed by broad-based strength. For investors wary of leaning on a single hot stock, a diversified approach like the Trefis High Quality Portfolio — about 30 companies selected for consistent cash flow and strong balance sheets — offers a way to capture momentum-style gains without concentration risk.